Lisa L. Decker
2021
In 2021, Lisa L. Decker earned a total compensation of $4.9M as Chief Business Officer at IGM Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $132,045 |
|---|---|
| Option Awards | $3,795,330 |
| Salary | $330,114 |
| Stock Awards | $599,900 |
| Total | $4,857,389 |
Decker received $3.8M in option awards, accounting for 78% of the total pay in 2021.
Decker also received $132K in non-equity incentive plan, $330.1K in salary and $599.9K in stock awards.
Rankings
In 2021, Lisa L. Decker's compensation ranked 2,714th out of 12,415 executives tracked by ExecPay. In other words, Decker earned more than 78.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,714 out of 12,415 | 78th |
Division Manufacturing | 1,072 out of 5,501 | 81st |
Major group Chemicals And Allied Products | 420 out of 2,371 | 82nd |
Industry group Drugs | 366 out of 2,092 | 83rd |
Industry Pharmaceutical Preparations | 242 out of 1,542 | 84th |
Source: SEC filing on April 27, 2022.
Decker's colleagues
We found three more compensation records of executives who worked with Lisa L. Decker at IGM Biosciences in 2021.